Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2012
12/20/2012WO2012174289A2 A novel fluorescence-based assay for the rapid detection and quantification of deoxyribonucleoside triphosphates
12/20/2012WO2012174282A2 Biomarker compositions and methods
12/20/2012WO2012174256A2 Dna methylation profiles in cancer
12/20/2012WO2012174225A2 Isolation, expansion and use of autologous pluripotent stem cells
12/20/2012WO2012174214A1 High resolution analysis of mammalian transcriptome using gene pool specific primers
12/20/2012WO2012174203A2 Methods and kits for the detection and treatment of recurring prostate cancer
12/20/2012WO2012174192A2 Method of amplifying a nucleic acid
12/20/2012WO2012174187A2 Methods, compositions, and kits for determining human immunodeficiency virus (hiv)
12/20/2012WO2012174142A1 Flat-field imaging system and methods of use
12/20/2012WO2012174129A1 Biomarkers for necrotizing enterocolitis and sepsis
12/20/2012WO2012174119A2 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains
12/20/2012WO2012174112A2 Systems and methods for an optical nanoscale array for sensing and recording of electrically excitable cells
12/20/2012WO2012173994A2 Phase changing formulations of nucleic acid payloads
12/20/2012WO2012173919A1 Method of processing a sample for analysis
12/20/2012WO2012173905A1 Salt-tolerant dna polymerases
12/20/2012WO2012173866A2 Methods of identifying an organism
12/20/2012WO2012173809A2 Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders
12/20/2012WO2012173636A1 Hiv incidence assays with high sensitivity and specificity
12/20/2012WO2012173358A2 Testis somatic cell-derived pluripotent stem cells, method for producing same, and pharmaceutical composition for impotence treatment including same
12/20/2012WO2012173274A1 Nucleic acid probe for assaying nucleic acids
12/20/2012WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals
12/20/2012WO2012173185A1 Method for measuring glycosylated hemoglobin, measurement reagent, and measurement kit
12/20/2012WO2012173015A1 Probe set and use thereof
12/20/2012WO2012172575A1 Genetic variants for predicting risk of breast cancer
12/20/2012WO2012172555A1 Combination therapy to prevent dcis formation and progression to breast cancer
12/20/2012WO2012172546A1 Target-recognition compositions comprising novel synthetic conjugates for trapping and diagnosis of a target molecule
12/20/2012WO2012172511A1 Method for the prognosis of breast cancer based on the expression of the gene pin1 in combination with mutations in the gene tp53
12/20/2012WO2012172221A2 Molecular signature of pigment spots on the skin, associated with extracellular matrix organization
12/20/2012WO2012172220A1 Molecular signature for skin pigment spots, which is combined with the extracellular matrix
12/20/2012WO2012171997A1 Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals
12/20/2012WO2012171990A1 Discrimination of blood type variants
12/20/2012WO2012171949A2 Thromboembolic disease
12/20/2012WO2012171922A1 Diagnostic device
12/20/2012WO2012171920A1 Treatment device
12/20/2012WO2012171334A1 Method for transdifferentiating fibroblast into liver stem cell
12/20/2012WO2012171213A1 Method and system for assembly of genome
12/20/2012WO2012171127A1 Automated size selection of nucleic acids
12/20/2012WO2012171112A1 Isolated embryonic stem cells that express lineage markers and associated methods
12/20/2012WO2012149193A3 Diagnostic molecular markers for seed lot purity traits in soybeans
12/20/2012WO2012138740A3 Risk analysis for disease development
12/20/2012WO2012135340A3 Compositions and methods for diagnosing cancer
12/20/2012WO2012135053A3 Rnase h-based assays utilizing modified rna monomers
12/20/2012WO2012130720A3 PREDICTION OF RESPONSIVENESS TO PIK3/mTOR INHIBITORS
12/20/2012WO2012121486A3 Gene analysis method using sdl-pcr
12/20/2012WO2012120374A3 Methods and biomarkers for detection of gastrointestinal cancers
12/20/2012WO2012115493A3 Biomarker for cancer, and cancer diagnosis using same
12/20/2012WO2012115464A3 Composition for hot-start pcr comprising blocking oligonucleotide
12/20/2012WO2012115454A3 Method for concentrating cells that are genetically altered by nucleases
12/20/2012WO2012112012A3 Simultaneous diagnosis kit for a disease due to a respiratory virus
12/20/2012WO2012109574A3 Assay methods using dna binding proteins
12/20/2012WO2012108706A3 Kit for diagnosing tamiflu-sensitive and resistant novel influenza a (h1n1) simultaneously and diagnosis method using same
12/20/2012WO2012108675A3 Pna aptamer able to isolate a metal
12/20/2012WO2012108669A3 Uranyl ion specific dna aptamer
12/20/2012WO2012102584A3 Sensor for detecting target virus, and method for screening target virus and analyzing mutation location using same
12/20/2012WO2012102527A3 Novel use of regulatory t cell-specific surface protein lrig-1
12/20/2012WO2012065043A9 Classification of nucleic acid templates
12/20/2012WO2012058638A3 Nucleic acid nanostructure barcode probes
12/20/2012WO2007012811A9 Prostate stem cell markers
12/20/2012US20120324603 Chimeric Endonucleases and Uses Thereof
12/20/2012US20120324599 Methods and Compositions for Gray Leaf Spot Resistance in Corn
12/20/2012US20120324598 Genetic loci associated with fusarium solani tolerance in soybean
12/20/2012US20120324593 Lysyl Oxidase-Like 1 (LOXL1) and Elastogenesis
12/20/2012US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
12/20/2012US20120322847 ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION
12/20/2012US20120322792 Method and Compositions for Treating Cancer and Related Methods
12/20/2012US20120322743 Compositions and Methods for Diagnosing and Treating Melanoma
12/20/2012US20120322717 Compounds and assays for controlling Wnt activity
12/20/2012US20120322689 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/20/2012US20120322688 Testing lumenectomy samples for markers of non-vascular diseases
12/20/2012US20120322687 Methods of predicting high grade gliomas using senescence associated genes
12/20/2012US20120322685 Device for collecting and analyzing migratory tumor cells
12/20/2012US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker
12/20/2012US20120322683 Enzymatic signal generation and detection of binding complexes in stationary fluidic chip
12/20/2012US20120322676 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains
12/20/2012US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer
12/20/2012US20120322673 Isolation of nucleic acid from mouth epithelial cells
12/20/2012US20120322670 Identifying genetic variation in affected tissues
12/20/2012US20120322669 Methods of marking materials
12/20/2012US20120322668 Assessment of solid tumor burden
12/20/2012US20120322667 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
12/20/2012US20120322666 Isolation of polymerase-nucleic acid complexes
12/20/2012US20120322146 Neural cell populations from primate pluripotent stem cells
12/20/2012US20120322113 Nucleic acid amplification
12/20/2012US20120322112 Crude biological derivatives competent for nucleic acid detection
12/20/2012US20120322109 Covalent Joining of DNA Strands to RNA Strands Catalyzed by Vaccinia Topoisomerase
12/20/2012US20120322098 Culture medium for screening or enrichment of methicillin-resistant s. aureus
12/20/2012US20120322097 Device and method for culturing cells in a biomimetic environment
12/20/2012US20120322094 High-molecular-weight adiponectin measurement method
12/20/2012US20120322092 Resonance Energy Transfer Assay with Synaptobrevin Substrate Moiety
12/20/2012US20120322091 Pharmacologic method of lowering cholesterol production
12/20/2012US20120322079 Method for testing or screening protein synthesis inhibitors
12/20/2012US20120322078 Production of Propanols, Alcohols, and Polyols in Consolidated Bioprocessing Organisms
12/20/2012US20120322075 Lung Tumor Markers and Methods of Use Thereof
12/20/2012US20120322074 Prostate Tumor Markers and Methods of Use Thereof
12/20/2012US20120322073 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
12/20/2012US20120322072 Quantification of a minority nucleic acid species
12/20/2012US20120322071 Method for quantitative measurement of gene expression for indentifying individuals at risk for bronchogenic carcinoma
12/20/2012US20120322070 Cryogenic biopsy system and method
12/20/2012US20120322069 Diagnositic Methods of Tumor Susceptibility With Nucleotide Polymorphisms Inside MicroRNA Target Sites
12/20/2012US20120322068 Method for identifying increased risk of anxiety disorders